Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space
Giulia Caron, Jan Kihlberg, Gilles H. Goetz, et al.
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 1, pp. 13-23
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 398
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development
Vincent Guerlavais, Tomi K. Sawyer, Luis A. Carvajal, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9401-9417
Closed Access | Times Cited: 60
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
Atsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 44, pp. 24035-24051
Closed Access | Times Cited: 39
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
Edward Price, Manuel Weinheimer, Alexey Rivkin, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5683-5698
Closed Access | Times Cited: 23
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
Bing Bai, Alexandr Belovodskiy, Mostofa Abu Hena, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2905-2925
Closed Access | Times Cited: 93
Impact of PROTAC Linker Plasticity on the Solution Conformations and Dissociation of the Ternary Complex
Dhanushka Weerakoon, Rodrigo J. Carbajo, Leonardo De Maria, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 340-349
Closed Access | Times Cited: 56
De novo molecular design with deep molecular generative models for PPI inhibitors
Jianmin Wang, Yanyi Chu, Jiashun Mao, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 44
Lessons for Oral Bioavailability: How Conformationally Flexible Cyclic Peptides Enter and Cross Lipid Membranes
Stephanie M. Linker, Christian Schellhaas, Anna S. Kamenik, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2773-2788
Open Access | Times Cited: 31
Explore drug-like space with deep generative models
Jianmin Wang, Jiashun Mao, Meng Wang, et al.
Methods (2023) Vol. 210, pp. 52-59
Closed Access | Times Cited: 22
Structural and Physicochemical Features of Oral PROTACs
Markus Schade, James S. Scott, Thomas G. Hayhow, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 13106-13116
Closed Access | Times Cited: 10
Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior
Ahmad Y. Sheikh, Alessandra Mattei, Rajni M. Bhardwaj, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 42, pp. 17479-17491
Open Access | Times Cited: 42
Advancing New Chemical Modalities into Clinical Studies
María‐Jesús Blanco, Kevin M. Gardinier, Mark Namchuk
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 11, pp. 1691-1698
Open Access | Times Cited: 34
Emerging Landscape of Computational Modeling in Pharmaceutical Development
Yuriy A. Abramov, Guangxu Sun, Qun Zeng
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 5, pp. 1160-1171
Closed Access | Times Cited: 33
Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five
Sven Stegemann, Chris Moreton, Sami Svanbäck, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103344-103344
Open Access | Times Cited: 33
Chamelogk: A Chromatographic Chameleonicity Quantifier to Design Orally Bioavailable Beyond-Rule-of-5 Drugs
Diego García Jiménez, Maura Vallaro, Matteo Rossi Sebastiano, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10681-10693
Open Access | Times Cited: 18
Macrocyclization as a Strategy for Kinetic Solubility Improvement: A Comparative Analysis of Matched Molecular Pairs
Carlo Walz, Moritz Spiske, Magnus W. Walter, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides
Shuzhe Wang, Gerhard König, Hans‐Jörg Roth, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 17, pp. 12761-12773
Open Access | Times Cited: 33
A New Amino Acid for Improving Permeability and Solubility in Macrocyclic Peptides through Side Chain-to-Backbone Hydrogen Bonding
Jaru Taechalertpaisarn, Satoshi Ono, Okimasa Okada, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 5072-5084
Open Access | Times Cited: 23
A story of peptides, lipophilicity and chromatography – back and forth in time
Vanessa Erckes, Christian Steuer
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 6, pp. 676-687
Open Access | Times Cited: 22
Conformational Sampling Deciphers the Chameleonic Properties of a VHL-Based Degrader
Giuseppe Ermondi, Diego García Jiménez, Matteo Rossi Sebastiano, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 272-272
Open Access | Times Cited: 14
Basic Nitrogen (BaN) Is a Key Property of Antimalarial Chemical Space
Harsha Valluri, Amritansh Bhanot, Shreeya Shah, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8382-8406
Closed Access | Times Cited: 14
Unnatural Amino Acids: Strategies, Designs, and Applications in Medicinal Chemistry and Drug Discovery
Krishna K. Sharma, Komal Sharma, Kamya Rao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19932-19965
Closed Access | Times Cited: 3
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin
Matteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 6, pp. 1652-1660
Closed Access | Times Cited: 23
Key Considerations in Targeted Protein Degradation Drug Discovery and Development
Liena Qin, Han Dai, Junfeng Wang
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 16
MicroED as a Powerful Tool for Structure Determination of Macrocyclic Drug Compounds Directly from Their Powder Formulations
Emma Danelius, Guanhong Bu, Lianne H. E. Wieske, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 12, pp. 2582-2589
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top